Montelukast sodium in cystic fibrosis.
A H
AH
Morice
J A
JA
Kastelik
I
I
Aziz
D000085:Acetates / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy; D003521:Cyclopropanes; D003550:Cystic Fibrosis / Q000188:drug therapy*; D017079:Exercise Tolerance / Q000187:drug effects; D005260:Female; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D008297:Male; D011804:Quinolines / Q000627:therapeutic use*; D013440:Sulfides; D016896:Treatment Outcome
D000085:Acetates; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast